Clinical Trials Directory

Trials / Completed

CompletedNCT02037750

Foster Teens' Risk During Transition

Foster Teens' Risk During Transition: Preventing Drug Use, HIV, & School Problems

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
173 (actual)
Sponsor
Oregon Social Learning Center · Academic / Other
Sex
All
Age
9 Years – 13 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to conduct a randomized effectiveness trial to determine whether adding a preventive intervention at the transition from elementary to middle school is effective and cost effective in terms of ameliorating outcomes such as drug and tobacco use, participation in HIV- risking sexual behavior, delinquency, mental health problems, and school failure for young adolescents in foster care. The proposed LINKS intervention marries the goals of child welfare and educational systems. The aims are: a) to determine the effectiveness of the LINKS intervention on key behavioral health and school adjustment outcomes, b) to examine mechanisms of action; specifically the mediating effects of placement failure on outcomes, c) to examine the moderating role of fidelity on outcomes, and d) to examine cost effectiveness and cost avoidance of LINKS.

Conditions

Interventions

TypeNameDescription
BEHAVIORALLINKSIn the LINKS, foster/kin parents will participate in weekly group meetings led by well-trained and supervised paraprofessional facilitators (school behavioral aids and foster parents) where the curriculum is based on parent management training (PMT). In previous studies, attendance at such groups has been high, averaging about 75-80%. Missed sessions will be "made up" with an in-person visit to the foster/kin home during the week of the original session. In addition, youth in the intervention condition will receive individual skill building sessions from a Life Skills Coach to increase their competency at goal setting, refusal skills, and peer relations.

Timeline

Start date
2012-12-01
Primary completion
2018-06-01
Completion
2018-06-01
First posted
2014-01-16
Last updated
2018-11-23

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02037750. Inclusion in this directory is not an endorsement.